Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Update on changes in Hepatitis B and C in CEE countries- Miłosz Parczewski, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Epidemiology of HIV Infection and Treatment in Europe- Teymur Noori, MSc

Slideset

HIV

Viral Hepatitis and Liver Disease

Country models: what has and what hasn’t worked- Nikoloz Chkhartishvili, MD, MS, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Country models: what has and what hasn’t worked- Zahedul Islam, MBA

Slideset

HIV

Viral Hepatitis and Liver Disease

Hepatitis Delta: what are the new developments, what are the challenges?- Cihan Yurdaydin, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Treatment-experienced patients in Central and Eastern Europe – What needs to be done?- Viktor Aster, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV & women’s health: do we have any game changers here?- Mariana Mărdărescu, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Clinical Case Discussion: Switching HIV Therapy- Pavel Khaykin, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Clinical considerations in switching antiretroviral therapy- David Jilich, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Possible misclassification of HIV transmission between men: results of phylogenetic analysis- Natia Dvali

Slideset

HIV

Viral Hepatitis and Liver Disease

Real-life effectiveness of ledipasvir/sofosbuvir regimen and factors associated with retention in care among HIV/HCV co-infected PWID in Ukraine- Tetyana Kyrychenko

Slideset

HIV

Viral Hepatitis and Liver Disease

Spontaneous HCV clearance in HCV/HIV coinfected patients from AIDS Center Prague- Viktor Aster

Slideset

HIV

Viral Hepatitis and Liver Disease

Epidemiology of HIV in the Baltic countries (Estonia, Latvia, Lithuania)- Saulius Caplinskas

Slideset

HIV

Viral Hepatitis and Liver Disease

Critical assessment of the global epidemiology of HCV- Peter Ferenci, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Liver transplantation for HCV and HBV in The Czech Republic- Soña Frankova, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

The EpiTer-2 database- Robert Flisiak, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Case Study: The changing IV drug use problem/pattern and what that means to the epidemic- Mojca Maticic, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Mortality and causes of death among HIV/HCV co-infected persons in the Eastern European country of Georgia- Akaki Abutidze

Slideset

HIV

Viral Hepatitis and Liver Disease

HCV resistance-associated variants among HCV treatment naïve HIVcoinfected patients in Ukraine. A pilot study- Marta Vasylyev

Slideset

HIV

Viral Hepatitis and Liver Disease

Hepatitis B cure strategies: how far are we?- Heiner Wedemeyer, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

New delivery systems and long acting antiretroviral drugs- David Back, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Early results of pre-exposure prophylaxis program in Georgia- Nikoloz Chkhartishvili

Slideset

HIV

Viral Hepatitis and Liver Disease

The Regression of Liver Fibrosis in HCV Cirrhotic Patients Who Registered SVR after DAA Therapy- Anca Leustean

Slideset

HIV

Viral Hepatitis and Liver Disease

Insulin-like growth factor and platelet-derived growth factor in liver cells of patients with chronic hepatitis C at different stages of fibrosis- Igor Tikhonov

Slideset

HIV

Viral Hepatitis and Liver Disease

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Update on changes in Hepatitis B and C in CEE countries- Miłosz Parczewski, MD, PhD

Epidemiology of HIV Infection and Treatment in Europe- Teymur Noori, MSc

Country models: what has and what hasn’t worked- Nikoloz Chkhartishvili, MD, MS, PhD

Country models: what has and what hasn’t worked- Zahedul Islam, MBA

Hepatitis Delta: what are the new developments, what are the challenges?- Cihan Yurdaydin, MD

Treatment-experienced patients in Central and Eastern Europe – What needs to be done?- Viktor Aster, MD, PhD

HIV & women’s health: do we have any game changers here?- Mariana Mărdărescu, MD, PhD

Clinical Case Discussion: Switching HIV Therapy- Pavel Khaykin, MD

Clinical considerations in switching antiretroviral therapy- David Jilich, MD

Possible misclassification of HIV transmission between men: results of phylogenetic analysis- Natia Dvali

Real-life effectiveness of ledipasvir/sofosbuvir regimen and factors associated with retention in care among HIV/HCV co-infected PWID in Ukraine- Tetyana Kyrychenko

Spontaneous HCV clearance in HCV/HIV coinfected patients from AIDS Center Prague- Viktor Aster

Epidemiology of HIV in the Baltic countries (Estonia, Latvia, Lithuania)- Saulius Caplinskas

Critical assessment of the global epidemiology of HCV- Peter Ferenci, MD

Liver transplantation for HCV and HBV in The Czech Republic- Soña Frankova, MD, PhD

The EpiTer-2 database- Robert Flisiak, MD, PhD

Case Study: The changing IV drug use problem/pattern and what that means to the epidemic- Mojca Maticic, MD, PhD

Mortality and causes of death among HIV/HCV co-infected persons in the Eastern European country of Georgia- Akaki Abutidze

HCV resistance-associated variants among HCV treatment naïve HIVcoinfected patients in Ukraine. A pilot study- Marta Vasylyev

Hepatitis B cure strategies: how far are we?- Heiner Wedemeyer, MD

New delivery systems and long acting antiretroviral drugs- David Back, PhD

Early results of pre-exposure prophylaxis program in Georgia- Nikoloz Chkhartishvili

The Regression of Liver Fibrosis in HCV Cirrhotic Patients Who Registered SVR after DAA Therapy- Anca Leustean

Insulin-like growth factor and platelet-derived growth factor in liver cells of patients with chronic hepatitis C at different stages of fibrosis- Igor Tikhonov

HIV PrEP- Pep Coll, MD